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Abstract
Background: In the genome of H. pylori 26695, 149 proteins containing the CXXC motif characteristic of thioldisulfide
oxidoreductases have been identified to date. However, only two of these proteins have a thioredoxin-like fold
(i.e., HP0377 and HP0231) and are periplasm-located. We have previously shown that HP0231 is a dimeric oxidoreductase
that catalyzes disulfide bond formation in the periplasm. Although HP0377 was originally described as DsbC homologue,
its resolved structure and location of the hp0377 gene in the genome indicate that it is a counterpart of CcmG/DsbE.
Results: The present work shows that HP0377 is present in H. pylori cells only in a reduced form and that absence of the
main periplasmic oxidase HP0231 influences its redox state. Our biochemical analysis indicates that HP0377 is a specific
reductase, as it does not reduce insulin. However, it possesses disulfide isomerase activity, as it catalyzes the refolding of
scrambled RNase. Additionally, although its standard redox potential is -176 mV, it is the first described CcmG
protein having an acidic pKa of the N-terminal cysteine of the CXXC motif, similar to E. coli DsbA or E. coli DsbC.
The CcmG proteins that play a role in a cytochrome c-maturation, both in system I and system II, are kept in the reduced
form by an integral membrane protein DsbD or its analogue, CcdA. In H. pylori HP0377 is re-reduced by CcdA (HP0265);
however in E. coli it remains in the oxidized state as it does not interact with E. coli DsbD. Our in vivo work also suggests
that both HP0377, which plays a role in apocytochrome reduction, and HP0378, which is involved in heme transport and
its ligation into apocytochrome, provide essential functions in H. pylori.
Conclusions: The present data, in combination with the resolved three-dimensional structure of the HP0377, suggest that
HP0377 is an unusual, multifunctional CcmG protein.
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Background
Disulfide bonds contribute to the stability and function
of many extracytoplasmic, soluble or membrane-bound
proteins. In gram-negative bacteria, the oxidative protein
folding takes place in the periplasm and is controlled by
proteins from the Dsb family [1]. In the highly oxidizing
environment of the periplasm, there is also a need for
selected proteins to be kept in a reduced form. In the
assembly of c-type cytochromes, essential for energy me-
tabolism, for example, the cytochrome c maturation
process requires ligation of heme (iron protoporphirin IX)
to reduced thiols of the Cys-X-X-Cys-His motif of apocyto-
chrome [2]. To date, there are two different systems for
cytochrome-c biogenesis that have been found in bacteria:
system I and system II. They comprise two kinds of pro-
teins acting in a coordinated fashion: those involved in
heme handling and heme ligation to the apocytochrome,
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and those contributing to reduction of a disulfide bond of
the CXXCH heme-binding motifs [3–5].
The cytochrome-c maturation machinery of the system I
operating in many gram-negative bacteria consists of up to
ten proteins (Ccm ABCDEFGHI and DsbD or its shorter
version CcdA). The apocytochrome reduction is accom-
plished by the action of CcmG (also known as DsbE),
CcmH, and DsbD or CcdA. DsbD/CcdA transfers electrons
from cytoplasmic thioredoxin to CcmG. Then CcmG is re-
oxidized by shuttling its electrons to CcmH, which finally
transfers them to apocytochrome c. However, the details
concerning mixed disulfide complexes created during the
process still remain unclear [6]. The remaining proteins
play a role in heme transport and its ligation to the apocy-
tochrome [4].
System II is simpler and more widespread among bacter-
ial species. It is present in, for example, gram-positive Bacil-
lus subtilis. It contains four proteins, ResA, ResB, ResC and
CcdA, of which ResA (also named CcsX or HelX) is a func-
tional counterpart of CcmG, and CcdA is a functional
counterpart of DsbD. ResB (also called CcsB and Ccs1) and
ResC (CcsA) form a complex to deliver the heme, and they
function in the cytochrome c-heme ligation [7]. While in
most microorganisms, the CcsB and CcsA proteins are
present as two separate polypeptides, there are a few spe-
cies of bacteria, such as Wolinella, Bacteroides and some
strains of Helicobacter spp., whose genes encode CcsA and
CcsB fused into one large ORF (called ccsBA) [8].
Many studies have tried to decipher the cooperation
among periplasmic Dsb proteins in cytochrome-c biogen-
esis. Initially, it was thought that introduction of the disul-
fide bonds into the CXXCH motif of the apocytochrome c,
which happens just after its transport to the periplasm by
the Sec system, is an obligatory step of the process, as dsbA
and dsbB mutants in E. coli were unable to produce cyto-
chrome c [9, 10]. However, recent data in the literature
may contradict this scheme; the lack of the Dsb proteins of
the oxidative pathway in B. subtilis and R. capsulatus, for
example, suppresses the cytochrome c deficiency of ccmG
or ccdA mutants [11–13]. However, it should be noted that
the Dsb oxidative pathway functioning is dependent on cell
growth conditions (anaerobic vs aerobic) It has also been
demonstrated that the heterologous expression of CcsBA of
H. pylori or CcsAB from B. pertussis, both encoding cyto-
chrome c synthetase, in an E. coli that lacks its own
cytochrome c machinery results in c-type cytochrome
formation. This observed effect was significantly en-
hanced by addition of exogenous reductant [14, 15].
Detailed analysis of the Paracoccus denitrificans cyto-
chrome maturation in an E. coli dsbA, dsbD double-mutant
led Mavridou et al. to the conclusion that apocytochrome is
subjected to two competing reactions: either heme attach-
ment to its cysteine thiols, or oxidation of those thiols
[16].
Helicobacter pylori is a gram-negative spiral-shaped
bacterium, a member of ε-Proteobacteria that specifically
colonizes the gastric epithelium of humans with severe
consequences. Data on H. pylori cytochromes are not
comprehensive. Analysis of its genome nucleotide sequence
revealed that this microaerophilic microorganism possesses
a rather simple respiratory chain consisting of three en-
zymes: quinol-cytochrome c reductase, cytochrome bc1
complex, cytochrome c553 and cb-type cytochrome c
oxidase [17]. Further inspection of the H. pylori genome
showed the existence of a second gene encoding a putative
low molecular mass cytochrome c (HP0236) named cycB.
Both cycA and cycB are essential genes and cannot sub-
stitute for each other [18]. Cytochrome c553, encoded
by the cycA (HP1227) gene, is a soluble periplasmic
protein, a potential electron donor to the cb-type cyto-
chrome c oxidase [18]. To our knowledge, little is
known about the c-type cytochrome maturation system
of Helicobacter pylori. In the genome of H. pylori
26695, there are 149 proteins containing CXXC motifs
characteristic of thiol:disulfide oxidoreductases identified to
date. Only two of these proteins have a thioredoxin-like
(TRX) fold (i.e., HP0377 and HP0231) and are periplasm-
located [19]. This microorganism uses system II, and
hp0377 (a homolog of resA) and hp0378 ((ycf5), a homolog
of resBC), whose products potentially play a central role in
c-type cytochrome maturation, constitute one transcrip-
tional unit [20, 21]. HP0378 can, to some extent, comple-
ment for a lack of the E. coli cytochrome-c maturation
machinery. The recently determined crystal structure of
HP0377 shows similarity to the structure of B. subtilis
ResA. However large structural differences between these
two proteins were also observed [22]. We have previously
demonstrated that HP0231 is a dimeric oxidoreductase that
catalyzes disulfide bond formation in the periplasm. In this
work, to gain further insight into the Helicobacter pylori
Dsb protein network, we analyzed HP0377, the second
periplasmic oxidoreductase, using biochemical and genetic
tools.
Methods
Bacterial strains, primers, plasmids, media and growth
conditions
Bacterial strains, plasmids and primers used in this study
are listed in Tables 1 and 2. Two H. pylori strains (26695
and N6) were used in this study. Although the sequence of
the H. pylori 26695 genome is complete [23], this strain is
inconvenient for genetic manipulation. H. pylori N6,
originally isolated from a patient with gastritis, is use-
ful for complementation experiments, and it is highly
motile [24]. Both H. pylori strains were grown on
blood agar base 2 (BA) plates (Merck) supplemented
with 10 % horse blood and an antibiotic mixture consisting
of vancomycin (final concentration, 12.5 μg ml−1),
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polymyxin B (1.25 μg ml−1), trimethoprim (6.25 μg ml−1)
and amphotericin B (2.5 μg ml−1) at 37 °C under micro-
aerobic conditions. Liquid cultures of H. pylori were grown
in Brain Heart Infusion (BHI) broth supplemented with
10 % fetal bovine serum (FBS). For the selection of H. pylori
mutants or complemented strains, kanamycin (25 μg ml−1)
or/and chloramphenicol (10 μg ml−1) were added to the
growth media.
The E. coli strain TG1 was used as a host for the
construction and preparation of recombinant plas-
mids. The E. coli strain Rosetta (DE3) was used to
overexpress pUWM518, pUWM2046 and pUWM2065.
The E. coli strains JCB817 and JFC383 were employed for
complementation experiments of E. coli dsbA and dsbC
mutants by HP0377. E. coli strains were grown at 37 °C on
solid or liquid Luria-Bertani (LB) medium or on M63 min-
imal medium [25]. When needed, media were supple-
mented with antibiotics at the following concentrations:
100 μg ml−1 ampicillin, 30 μg ml−1 kanamycin and 20 μg
ml−1 chloramphenicol.
General DNA manipulations
Standard DNA manipulations were carried out as de-
scribed earlier [26] or according to the manufacturer’s
Table 1 Bacterial strains and plasmids used in this study
Name Genotype or relevant characteristics Origin
Helicobacter pylori strains
26696 H. pylori wild-type ATCC
N6 H. pylori wild-type [24]
PR305 N6 dsbI::aph [31]
PR336 dsbI+ in trans complementant of dsbI::aph [31]
PR378 N6 hp0231::cat [31]
PR397 hp0231+ in trans complementant of
hp0231::cat
[31]
MG100 N6 hp0265::aph This study
Escherichia coli strains
BL21 (DE3) F- ompT hsdSB(rB-mB-) gal dcm lon Novagen
Rosetta (DE3)
LacIq
F- ompT hsdSB (rB- mB-) gal dcm pRARE
(Cmr)
Novagen
TG1 supE44 hsdΔ 5 thi Δ(lac- proAB) F’ [traD36
proAB + lacIq lacZΔM15]
[26]
Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZ ΔM15
ΔlacX74 deoR nupG recA1 araD139 Δ(ara-leu)
7697 galU galK rpsL(strr) endA1 λ-
Gibco BRL
JCB816 MC1000 phoR λ102 [72]
JCB817 JCB816 dsbA::kan1 [72]
JFC383 JCB816 dsbC::kan J.F. Collet
Collection
FED126 MC1000 ΔdsbD [73]
JFC571 JFC383/pHEL2 This study
JFC572 JCF383/pUWM500 This study
JFC573 JF383/pUWM399 hp0377+ This study
PR501 JCB817/pHEL2 This study
PR502 JCB817/pUWM399 hp0377+ This study
PR539 FED126/pUWM399 hp0377+ & pUWM536 This study
PR540 JCB816/pUWM399 hp0377+ & pUWM536 This study
PR580 FED126/pUWM399 hp0377+ This study
PR581 JCB816/pUWM399 hp0377+ This study
General cloning/Plasmid vectors
pET28a Kmr, IPTG inducible Novagen
pGEM-T Easy Apr; LacZa Promega
pBlusescript
SK II
Amr, LacZa Stratagene
pHEL2 Cmr E. coli/H. pylori shuttle vector [74]
pMPM-K6Ω Kmr,Spr; ori f1, ori P15A; arabinose inducible [75]
pRY109 Cmr [76]
pUOA13 KmR,TetR [77]
pILL2150 Cmr E.coli/H. pylori shuttle vector; IPTG
inducible
[47]
Plasmids for mutagenesis
pUWM505 pGEM-T Easy/hp0377::aph This study
pUWM529 pGEM-T Easy/hp0377::aph This study
pUWM555 pGEM-T Easy/hp0377::aph This study
Table 1 Bacterial strains and plasmids used in this study
(Continued)
pUWM2019 pBluescript II SK/hp0265::aph This study
Plasmids for recombinant protein synthesis and purification
pUWM518 pET28a/hp0377 This study
pUWM2046 pET28a/hp0377 C89S This study
pUWM2065 pET28a/hp0377 C92S This study
pUWM2090 pET24a/hp1227 This study
pET28a-dsbA pET28a/EcdsbA J.F. Collet
Collection
pET28a-dsbC pET28a/EcdsbC J.F. Collet
Collection
pUWM525 pET28a/hp0231 [31]
Other plasmids
pUWM500 pHEL2/hp0231 [31]
pUWM336 pHEL2/dsbI [78]
pUWM399 pHEL2/hp0377 This study
pUWM389 pGEM-T Easy/hp0231 This study
pUWM536 pMPM-K6Ω/hp0265 This study
pUWM543 pGEM-T easy/hp0377 This study
pUWM544 pGEM-T easy/hp0377 without promoter and
signal sequence
This study
pUWM2045 pGEM-T easy/hp0377 C89S This study
pUWM2064 pBluescript II SK/hp0377 C92S This study
pUWM2073 pBluescript II SK/hp0377 C25A This study
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instructions (A&A Biotechnology). Polymerase chain
reactions (PCR) were performed with PrimeStar HS
DNA Polymerase (Takara) or HotStar HiFidelity Poly-
merase (Qiagen) under standard conditions. Synthetic
oligonucleotides synthesis and DNA sequencing were
performed by Genomed S.A., Warsaw, Poland.
Natural transformation of H. pylori
The naturally competent H. pylori N6 was grown on
BA plates for 24 h. Subsequently, bacteria were plated
onto fresh plates for 5 h. Then 0.5–1 μg of plasmid
DNA was added and plates were incubated for 22 h.
Afterwards, bacteria were transferred onto a plate sup-
plemented with kanamycin or chloramphenicol/kana-
mycin, and transformants were grown for 5 days.
Allelic exchange mutagenesis of the hp0265 gene in H. pylori
To inactivate hp0265, a recombinant vector was con-
structed by a two-step PCR method [27]. The
upstream and downstream regions of the hp0265 gene
were amplified from H. pylori N6 genomic DNA
using two pairs of primers specific for hp0265 and its flank-
ing regions, N6_HP0265_up_BamHI-N6_HP0265_up_rev1
and N6_HP0265_dw_SalI-N6_HP0265_dw_fwd, respect-
ively. The N6_HP0265_up_rev and N6_HP0265_dw_SalI
primers contained nucleotide sequences complementary to
each other, respectively. Each PCR product was purified
with a Gel extraction kit (A&A Biotechnology). Next, a
mixture of two purified products (in equal amounts)
was used as a template in a single PCR reaction, using
the primers N6_HP0265_up_BamHI-N6_HP0265_dw_fwd.
Table 2 Primers used in this study
Name Sequence 5′ – 3′ Orientation/Restriction site
hp377I GGCGATACTTACCAGCAAG Fwd/Ø
hp377II ATCCACTTTTCAATCTATATCTGTCTATATTGTCTCGCTCATC Rev/Ø
hp377IIa CAAGGCAAT CTGCCTCCTCATGTCTATATTGTCTCGCTCATC Rev/Ø
hp377IIIa GGATGAATTGTTTTAGTACCAATTTATCGGCGATGGGAAG Fwd/Ø
hp377IV GTTTGGTGGTGTCATTAAGAGTG Rev/Ø
hp377ex1 GAGGCCATGGGCAAATCCAACAATAAAGAC Fwd/NcoI
hp377ex2 GTGCTCGAGGTTAGACTTGCTTTTAGAAAG Rev/XhoI
HP0377zew1 CTAAGGTGCGAGTAATAGAG Fwd/Ø
HP0377zew2 CTATGCCTTCATTCCTGTTG Rev/Ø
hp0377mutF GAGGCATATGATGTTTTCACTTTCTTATGTTTCC Fwd/NdeI
hp0377mutR GAGGATCCCTAGTTAGACTTGCTTTTAGAAAG Rev/BamHI
N6_377_C89S_for CTTTCGCAATAGGAGCTACCATTACGCCCAAAAACTAAAA Fwd/Ø
N6_377_C89S_rev CTTTCGCAATAGGAGCTACCATTACGCCCAAAAACTAAAA Rev/Ø
hp377_C92SII GTTTTTGGCCGTAATGGTTGCTCCTATTCCGAAAG Fwd/Ø
hp377_C92SII_rev CTTTCGGAATAGGAGCAACCATTACGGCCAAAAAC Rev/Ø
hp377_C25A_for ATTGATTTCGCTGTTTTTAAGCGCTGCCAAATCCAACAAT AAAGACAAGTTA Fwd/Ø
hp377_C25A_rev TAACTTGTCTTTATTGTTGGATTTGGCAGCGCTTAAAAAC AGCGAAATCAAT Rev/Ø
N6_HP0264_fwd1 GATAGTAAGGGCGTGAGG Fwd/Ø
N6_HP0265_up_Bam AAGGGATCCGCGATTAAAGAGAGCTT Fwd/BamHI
N6_HP0265_dw_Sal TTAAGCGTAGCGATGTCGACTAGTTG Rev/SalI
N6_HP0265_rev1 GGCGTAATGGCTGATGAG Rev/Ø
N6_HP0265_up_rev TAGCTGCAGCCCGGGTAGCCACCACAAACATCAAGGG Rev/Ø
N6_HP0265_dw_fwd CTACCCGGGCTGCAGCTATCCTTATGGTGGTGTTTG Fwd/Ø
KM1f TGAGGAGGCAGATTGCCTTG Fwd/Ø
KM2r GGTACTAAAACAATTCATCC Rev/Ø
1hp265F-6HisNew GAGCCATGGCACACCACCACCACCACCACATGTTTGATAACACGCTTG Fwd/NcoI
2hp265RPstI GTGCTGCAGCTATTTTTGCAAGAAATTCGTCAGAC Rev/PstI
Hp1227_NdeI-for GCGCATATGACCGATGTTAAAGCCCTTG Fwd/NdeI
Hp1227_XhoI-rev CGCTCGAGTTTGAGGGTGGGGATGTAT Rev/XhoI
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The resulting PCR product contained a 274-nucleotide de-
letion of hp0265. The product was purified and cloned into
pBluescript SK II. To add the aph gene between the two
hp0265 arms, SmaI restriction enzyme was used to yield
suicide plasmid pUWM2019.
Sequence analyses confirmed the correct construction
of pUWM2019 and the recombinant plasmid was intro-
duced into H. pylori N6 by natural transformation. Cells
were plated and screened on plates containing kanamy-
cin and kanamycin with 2 mM DTT to restore the redu-
cing activity of HP0265.
An hp0265::aph mutant was obtained by a double cross-
over using pUWM2019, and verified by PCR analysis, using
the primer pair N6_Hp0264_fwd1-N6_HP0265_rev1.
Allelic exchange mutagenesis of the hp0377 gene in H.
pylori
To inactivate hp0377, two recombinant vectors, pUMW529
and pUWM555, were constructed. pUWM529 was gener-
ated by a two-step PCR method [27]. Briefly, primers
Km1f–Km2r, were used to amplify the aph gene from
pUWM505. The upstream and downstream regions of the
hp0377 gene were amplified from H. pylori N6 genomic
DNA using two pairs of primers specific for hp0377
and its flanking regions, hp0377I-hp0377IIa and hp0377IIIa-
hp0377IV, respectively. The hp0377IIa and hp0377IIIa
primers contained 5′ leader nucleotide sequences
complementary to Km1f and Km2r, respectively [28].
Each PCR product was purified with a Gel extraction
kit (A&A Biotechnology). Next a mixture of three
purified products (in equal amounts) was used as a
template in a single PCR reaction, using primers:
hp0377I-hp0377IV. Subsequently, the resulting PCR
product, containing the aph gene inserted between the
two hp0377 arms in the same transcriptional orientation as
the hp0377 gene, was purified and cloned into pGEM-T
Easy, generating the suicide plasmid pUWM529. Sequence
analyses confirmed the correct construction of pUWM529,
and the recombinant plasmid was introduced into H. pylori
N6/pUWM509 by natural transformation. Selection
was done on blood agar plates containing kanamycin
and chloramphenicol, with or without isopropyl-β-d-
thiogalactopyranoside.
The pUWM555 plasmid used for insertional mutagenesis
of the H. pylori N6 hp0377 gene, was constructed by ampli-
fication of the hp0377 gene and surrounding DNA
fragments by PCR, using the hp0377zew1-hp0377zew2
primers. Subsequently, the resulting PCR product was
purified and cloned into pGEM-T Easy, creating
pUWM543. The resulting construct was digested with
BglII, to cut the restriction site in the middle of
hp0377 gene. The sticky ends were blunted using Klenow
Fragment. The DNA mixture was purified with a Clean-up
kit and ligated with a previously prepared kanamycin
cassette, amplified from pUWM505 by the pair of primers
Km1f–Km2r. The generated suicide plasmid pUWM555,
containing the aph gene inserted between the two
hp0377 arms in the same transcriptional orientation as
the hp0377 gene, was confirmed by sequencing. The re-
combinant plasmid was introduced into H. pylori N6/
pUWM509 by natural transformation. Selection was
done on blood agar plates containing kanamycin and
chloramphenicol, with or without isopropyl-β-d-
thiogalactopyranoside.
To create a conditional mutant in the hp0377 gene,
pUWM509 was constructed based on the shuttle E. coli/
H. pylori plasmid: pILL2150. The hp0377 coding nucleo-
tide sequence was amplified from H. pylori 26695 gen-
omic DNA without its own promoter by the primer pair
hp0377mutF - hp0377mutR. The purified PCR products,
as well as the shuttle plasmid, were digested with NdeI/
BamHI and ligated together to form pUWM509. Correct
construction of pUWM509 was confirmed by sequen-
cing. Next, pUWM509 was introduced into H. pylori
N6, and pUWM529/pUWM555 was used to inactivate
hp0377 gene. The strategy for cloning into pILL2157
was identical.
Site-directed mutagenesis of the hp0377 gene
To obtain mutated HP0377 proteins, a set of recombinant
plasmids was constructed from pUWM544, which carries
the hp0377 gene without its promoter and signal sequence.
Cys-to-Ser point mutations were generated using the Quick
Change Site-Directed Mutagenesis Kit (Qiagen) according
to the manufacturer’s instructions, starting with 100
ng of pUWM544 template and 125 ng of each primer
(primer pairs: N6_377_C89S_for- N6_377_C89S_rev,
hp377_C92SII- hp377_C92SII_rev).
To obtain C25A mutated HP0377 protein, a recombinant
plasmid was constructed from pUWM399 carrying the
hp0377 gene with its promoter and signal sequence.
The Cys-to-Ala point mutation was generated as de-
scribed above, using primers hp377_C25A_for and
hp377_C25A_rev.
Protein analysis
Preparation of H. pylori and E. coli protein extracts,
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel
electrophoresis) and blotting procedures were performed
by standard techniques [26].
Preparation of subcellular fractions
Subcellular protein fractions were prepared from 48-h
H. pylori cultures. Periplasmic proteins were released
from the cells using an osmotic-shock procedure [29].
After decanting the periplasmic fraction, bacterial pellets
were resuspended in 20 mM Tris–HCl, pH 7.5 and soni-
cated to release the cell contents. Subsequently, cell wall
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debris was removed and the supernatants were ultracentri-
fuged (100,000 g, 4 °C, 30 min) to separate the membrane
and cytoplasmic fractions. Finally, the cell envelope was
fractionated into inner and outer membranes by selective
solubilization of the inner membrane with 2.0 % (wt/vol)
sodium lauryl sarcosine [30].
Overexpression and purification of apocytochrome c
(HP1227) and HP0231
HP0231 was overexpressed by autoinduction from an E.
coli Rosetta/pUWM525 strain and purified as previously
described [31].
HP1227 expression vector was constructed by ampli-
fying the region encoding the mature HP1227 protein
(without the signal sequence, amino acid residues 1–19)
from the chromosome of H. pylori 26695, with
primers Hp1227_NdeI-for and Hp1227_XhoI-rev. The
insert was cloned into pET24a with NdeI and XhoI
restriction enzymes, to yield plasmid pUWM2090. Ex-
pression was induced by 1 mM IPTG (isopropyl β-D-
1-thiogalactopyranoside) at OD600 ~ 0.6. After 4 h in
37 °C, cultures were centrifuged and the cell pellet
was suspended in 50 mM sodium phosphate, pH 8.0,
300 mM NaCl, 10 mM imidazole. Cells were disrupted
by ultrasonication. The cell lysate was centrifuged and
the resulting supernatant was applied onto Bio-Scale
Mini Profinity IMAC Cartridges (Bio-Rad) containing
Ni-charged resin. The protein was eluted with an
imidazole gradient, using the NGC chromatography
system (Bio-Rad).
Overexpression and purification of HP0377
HP0377 expression vector was constructed by amplifying
the region encoding the mature HP0377 protein (without
the signal sequence, amino acids 1–24) from the chromo-
some of H. pylori 26695, with primers hp377exI and
hp377exII. The insert was cloned into pET28a with NcoI
and XhoI restriction enzymes, to yield plasmid pUWM518.
The cytoplasm-located HP0377 was overexpressed
from pUWM518 by autoinduction [32], and then it was
purified by affinity chromatography, dialyzed against Phos-
phate Buffered Saline (Sigma) and later used for rabbit
immunization (Animal Facility, Faculty of Biology,
University of Warsaw). The anti-HP0377 rabbit serum
was specific and recognized native HP0377, as verified
by Western blot analysis.
The HP0377 C89S and C92S expression vectors were
constructed by cutting out hp0377-changed sequences
from pUWM2045 and pUWM2064, respectively, and
cloning the inserts into pET28a as described above,
resulting in formation of pUWM2046 and pUWM2065.
All plasmids carried the HP0377-His6 translation fusion.
For biochemical experiments, the protein was expressed
and purified from E. coli Rosetta harboring pUWM518,
pUWM2046 and pUWM2065. The proteins were over-
expressed by autoinduction and then purified by affinity
chromatography using NGC Medium-Pressure Chroma-
tography Systems by Bio-Rad as described above.
Biochemical assays
In vivo redox state of HP0377
The redox state of HP0377 was visualized by alkylat-
ing the free cysteine residues using 4-acetamido-4′-
maleimidylstilbene-2,2′-disulfonic acid (AMS, Invitrogen).
This agent can only modify covalently free thiols, resulting
in a molecular mass increase of 490 Da [31, 33, 34]. Briefly,
bacteria were harvested from BA plates after 24 or 48 h of
incubation under microaerobic conditions. Samples were
standardized using the OD600 of the culture, and ice-cold
trichloroacetic acid (TCA, final concentration 10 % v/v)
was immediately added to the culture. Whole-cell proteins
were precipitated and collected by centrifugation, washed
with ice-cold acetone, and then dissolved in 50 mM Tris–
HCl (pH 7.5), 10 mM ethylenediaminetetraacetic acid
(EDTA), 0.1 % SDS containing 20 mM AMS by agitation
for 60 min at 37 °C. The proteins in non-reducing Laemmli
buffer were resolved by 14 % SDS-PAGE without reducing
agent. HP0377 was then detected by an immunoblot
analysis using an anti-HP0377 antibody. As controls,
we used samples previously treated with 100 mM
ditiotreitol (DTT) for 30 min at 30 °C before precipita-
tion of the proteins with TCA.
Determination of the pKa value
The pH-dependent ionization of the Cys89 and Cys92
was followed by the specific absorbance of the thiolate
anion at 240 nm [35]. Measurements were carried out at
25 °C in a buffer consisting of 10 mM Tris, 10 mM so-
dium citrate, 1 mM EDTA and 200 mM NaCl, pH 11,
for EcDsbA as a control, and for HP0377 and its mu-
tated forms, with an average initial protein concentration
of 20 μM. The pH of the protein solution was lowered
to 2 by the stepwise addition of aliquots of 0.2 M HCl.
Absorbances at 240 and 280 nm were recorded on a
spectrophotometer and corrected for the volume increase.
The pH dependence of the thiolate specific absorbance sig-
nal (S = (A240/A280)reduced/(A240/A280)oxidized) was fit-
ted according to the Henderson-Hasselbach equation.
Determination of the redox potential of HP0377
The fractions of reduced and oxidized HP0377 were deter-
mined using 4-acetamido-4′-maleimidylstilbene-2,2′-
disulfonic acid (AMS) trapping [33]. Briefly, HP0377
(1 μM) were incubated overnight at room temperature
in 50 mM KPi pH 7.0, 0.1 mM EDTA and various
glutathione (GSH)/glutathione disulfide (GSSG) ratios.
After incubation, proteins were precipitated with
trichloroacetic acid (TCA) (10 % final concentration).
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After 20-min incubation on ice, the samples were centri-
fuged (16,100 × g, 5 min, 4 °C), and the pellets were washed
with cold acetone. After a second centrifugation, pellets
were dried and resuspended in a buffer containing 20 mM
AMS, 0.1 % SDS, 10 mM EDTA, and 50 mM Tris–HCl
(pH 7.5). After 45-min incubation at 37 °C, with
1,400 rpm shaking samples were loaded onto 12 %
SDS-polyacrylamide gels under denaturing conditions.
Fractions of reduced and oxidized protein were deter-
mined using ImageJ). The redox potential was then
calculated as described previously [36].
Alkaline phosphatase (AP) assay
AP activity was measured as previously described [37],
with some modifications. Briefly, E. coli cell cultures
were grown at 37 °C in minimal medium M63 until they
reached mid-log phase. Then, the cells were pelleted by
centrifugation, washed twice with Tris–HCl (pH 8.0),
and resuspended in Tris–HCl (pH 8.0). The OD600 was
measured spectrophotometrically. Samples (1 ml) were
equilibrated for 5 min in a water bath at 28 °C, then
200 μl p-nitrophenol phosphate [0.4 % (w/v) in Tris–
HCl (pH 8.0)] was added, and the time was recorded.
The reaction was allowed to proceed at 28 °C until de-
velopment of yellow color was observed. At this point
the reaction was stopped by adding 200 μl 1 M
KH2PO4. Samples were centrifuged before the A420
and A550 measurements.
Insulin reduction assay
The ability of HP0377 and EcDsbA to catalyze the re-
duction of insulin in the presence of DTT was deter-
mined as previously described [38].
Determination of oxidase and isomerase activities
Oxidative folding of reduced RNaseA
In vitro oxidative folding of reduced RNaseA was per-
formed for HP0377 and EcDsbA as described earlier,
with a few modifications [39, 40]. Proteins were oxidized
with 50 mM oxidized glutathione (GSSG) and incubated
for 1 h at room temperature. RNaseA was reduced by
overnight incubation at room temperature in 100 mM
Tris acetate pH 8.0 containing 6 M guanidine hydro-
chloride and 140 mM DTT. All proteins were then dia-
lyzed on desalting columns (Bio-Rad) and concentrated
in PBS. Native RNaseA and EcDsbA were used as posi-
tive controls. The redox state of the thiols was con-
firmed by Ellman’s assay, which exploits the colorimetric
change at A412 when 5,5′-dithiobis-(2-nitrobenzoic acid)
(DTNB; ThermoScientific) is converted to 2-nitro-5
thiobenzoate upon cleavage of the disulfide bond by free
thiols.
Oxidase activity was measured by analyzing the cleavage
of cCMP (Sigma; cytidine 2′:3′-cyclic monophosphate
monosodium salt) at A296 by refolded RNaseA in the pres-
ence of tested enzymes. Reactions (triplicate) were carried
out in 200 μl of PBS buffer containing 100 mM Tris acetate
pH 8.0, 2 mM EDTA, 0.2 mM GSSG, 1 mM GSH (reduced
glutathione), 4.5 mM cCMP, RNaseA (10 μM) and analyzed
enzyme (20 μM). The reaction mixtures were prepared in a
96-well plate format and read through 30 min at 27 °C in a
Sunrise™ (Tecan) plate reader. Three independent experi-
ments were performed.
Refolding of scrambled RNaseA
In vitro refolding of scrambled RNaseA was performed
for HP0377 and EcDsbC as described earlier, with a few
modifications [41, 42, 39]. Proteins were reduced with
100 mM DTT and incubated overnight at 4 °C. RNaseA
was first reduced by overnight incubation at room
temperature in 100 mM Tris acetate pH 8.0 containing
6 M guanidine hydrochloride and 140 mM DTT. Then,
in order to introduce incorrect disulfides, reduced RNa-
seA was dialyzed against PBS buffer containing 6 M
guanidine hydrochloride, sparged with oxygen and incu-
bated for 3 days in the dark at room temperature. Fi-
nally, 2 mM hydrogen peroxide (Sigma) was added for
30 min at 25 °C. All proteins were then dialyzed on
desalting columns (Bio-Rad) and concentrated in PBS.
EcDsbC was used as a positive control. The redox state
of the thiols was confirmed by Ellman’s assay.
RNaseA activity was measured by analyzing the cleav-
age of cCMP as described for the oxidative test, with a
change in the reaction mixture: 100 mM Tris acetate pH
8.0, 2 mM EDTA, 10 μM DTT, 4.5 mM cCMP, RNaseA
(40 μM) and analyzed enzyme (20 μM). Three independ-
ent experiments were performed.
Determination of the interaction between HP0231 and
HP1227
Oxidized HP0231 was prepared by incubating the puri-
fied HP0231 with a 100 mM oxidized glutathione for 1 h
at 37 °C. Reduced apocytochrome c was prepared by in-
cubating the purified apocytochrome with 10 mM DTT
for 1 h at 37 °C. Excess DTT and oxidized glutathione
was removed using desalting columns that were previ-
ously equilibrated with 20 mM Tris HCl pH 7.9, 150
mM NaCl. Reduced apocytochrome c in 20 mM Tris–HCl
pH 7.9, 150 mM NaCl was incubated for 3 h at 37 °C in the
presence of a twofold excess of HP0231ox. After incubation,
the proteins were precipitated with trichloroacetic acid
[final concentration 10 % (w/v)], washed three times with
ice-cold acetone and then resuspended in 100 μl of a
reaction buffer consisting of 50 mM Tris–HCl pH 6.8,
2 % (w/v) SDS, 10 mM AMS. The oxidized and reduced
forms of HP0231 as well as reduced apocytochrome c were
similarly treated with AMS before SDS–PAGE under non-
reducing conditions. AMS-treated protein samples were
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separated by nonreducing SDS–PAGE and visualized by
Coomassie staining.
Size exclusion chromatography
To verify that HP0377 exists as a monomeric protein,
size exclusion chromatography was employed. HP0377
was loaded onto Superdex75 HiLoad 16/600 column
(GE Healthcare) and eluted with 20 mM Tris pH 8, 150
mM NaCl.
Determination of the oligomeric state of HP0377 using
glutaraldehyde
Crosslinking of polypeptide chains with glutaraldehyde
was performed essentially as described [43].
HP0377 (2.5 mg/ml) was incubated at room temperature
with different concentration of glutaraldehyde (0.001-
0.1 % v/v) in 0.05 M bicine–NaOH buffer (pH 8.5), 0.1
mM DTT, 0.4 M NaCl for 20 min and the reaction
was quenched by adding ethanolamine–HCl (pH 8.0)
to a final concentration of 0.14 M.
Phenotype assays
DTT sensitivity assay
DTT sensitivity experiments were performed as previ-
ously described [40]. A freshly prepared 1 M DTT
(Applichem) stock solution was dissolved in molten LB
agar to the final concentration of 12 mM DTT. The
DTT agar plates were used within 30 min of pouring to
prevent oxidation of DTT by air. Exponentially growing
cultures were decimally diluted, and 7 μl aliquots were
spotted on the plates. The growth was observed after
overnight incubation at 37 °C. The experiments were
conducted in triplicate.
Motility assays
E. coli cells were grown in liquid culture in LB broth until
the OD600 value was close to 1. Then bacteria were inocu-
lated on LB soft agar plates containing 0.35 % (w/v) agar
with a sterile toothpick and incubated for 18 h at 30 °C.
Copper sensitivity assay
The copper sensitivity assay was performed as previously
described [31]. Briefly, bacteria were grown in BHI
media supplemented with 8 mM or 10 mM CuCl2.
Strains were grown at 34 °C.
Ethics statement
All studies involving animals were performed in ac-
cordance with ethical standards, after approval from
the Local Ethics Committee No. 1, Warsaw, Poland
966/2009.
Results
Determination of the in vivo redox state of HP0377
HP0377 is an oxidoreductase, as it contains the TRX
domain with a CXXC (CSYC) motif located at the
N-terminus of the first helix in the TRX fold. The in-
volvement of HP0377 in the cytochrome c maturation
process is indicated by its structure, its in vitro inter-
action with HP1227 (cytochrome c553) and the genetic
organization of the DNA fragment containing the
hp0377 gene [20, 22].
To clearly define whether HP0377 functions in the
oxidizing pathway or the reducing pathway, we first de-
cided to determine the redox state of that protein in vivo
using the AMS-trapping technique [33]. The in vivo
redox state of an oxidoreductase usually reflects its ac-
tivity in the cell, i.e., proteins that function in the oxidiz-
ing pathway, such as EcDsbA, are maintained in the
oxidized state in vivo, whereas proteins that function in
the reducing pathway, such as CcmG, are maintained
predominantly in the reduced state. We found that
HP0377 is present in the reduced form in wild-type
cells, which suggests that HP0377 functions as a reduc-
tase in H. pylori, which is in accord with its three dimen-
sional structure [22].
Thus, we also determined the redox status of the
HP0377 in H. pylori lacking HP0231 or DsbI (HP0595).
Both proteins are active in the Dsb oxidative pathway.
As described earlier, HP0231 introduces disulfide bonds
and DsbI is partially responsible for HP0231 re-oxidation
[31]. Our results showed that a significant portion of
HP0377 is present in the oxidized form in both the hp0231
and dsbI mutated cells (Fig. 1). Also the overproduction of
HP0231 or DsbI from a moderate copy number plasmid
disturbs the redox homeostasis and results in the presence
Fig. 1 Redox state of HP0377 in wt and mutants: hp0231::cat, dsbI::aph
and complemented strains of H. pylori strain N6. Bacterial cultures were
treated with 10 % TCA, followed by alkylation with AMS. Cellular proteins
including the reduced (red; DTT treated, modified with AMS) and the
oxidized (ox; non-modified with AMS) controls were separated by 14 %
SDS-PAGE under non-reducing conditions, and Western blot analysis
antibodies against HP0377 was performed. Each lane contains
proteins isolated from the same amount of bacteria
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of HP0377 in both reduced and oxidized forms (Fig. 1). To
clarify the link between HP0231 and cytochrome c biogen-
esis, we decided to check whether apocytochrome c is a
substrate of HP0231. We found that HP0231 was able to
oxidize the reduced apocytochrome c in vitro (Fig. 2).
Biochemical characterization of HP0377
To clearly define whether HP0377 functions as oxidore-
ductase, we analyzed the biochemical properties of the
protein. Recombinant proteins used for biochemical ana-
lysis were produced as cytoplasmic proteins in E. coli
cells and purified by affinity chromatography. First, to
gain insight into the role played by HP0377, we deter-
mined its redox potential by equilibrium incubation
using GSH/GSSG as a reference. We found that the
HP0377 redox potential is – 171 mV (Additional file 1:
Figure S1), which makes it a rather weak reductant.
Next we determined the ability of HP0377 to reduce
insulin in the presence of DTT. The insulin reduction
assay is commonly used to determine whether a protein
can function as an oxidoreductase, regardless of its func-
tion in the reducing or the oxidizing pathway in vivo. In-
sulin contains two intramolecular disulfide bonds that
connect the A and B chains: reduction of these disulfide
bonds causes the precipitation of the B chain, which can
be monitored by following the increase of turbidity at
650 nm [38]. As shown in Additional file 2: Figure S2,
the reaction lag time with HP0377 in the insulin reduc-
tion assay is almost as long as the control reaction
(about 60 min), whereas the lag time with EcDsbA is 24
min. Therefore, HP0377 likely cooperates with a specific
substrate, which is typical of CcmG proteins. However,
these data are in contrast to some previous data [22]. To
clarify this inconsistency, and because there is a similarity
between the active site of HP0377 (CSYC motif and Thr in
cis-Pro loop) and the disulfide isomerase EcDsbC (CPYC
motif and Thr in cis-Pro loop), we performed a disulfide
isomerase assay by evaluating the ability of HP0377 to re-
activate oxidized, scrambled RNase (scRNaseA). ScRNase
was prepared as described in the methods section and did
not contain free cysteines, as confirmed with Ellman re-
agent. In this assay, the refolding efficiency of HP0377 was
almost as high as EcDsbC (Fig. 3). To get a complete bio-
chemical characterization of HP0377, we also investigated
its ability to catalyze the refolding of reduced-unfolded
RNaseA. As expected, HP0377 did not show activity in this
assay (Additional file 3: Figure S3). As HP0377 revealed
high isomerizing activity, and because Dsb proteins in-
volved in the isomerization pathway exist as dimers, we also
evaluated the potential oligomerization of HP0377 using
two methods (gel filtration and glutaraldehyde crosslinking
strategy) (Figs. 4, 5) HP0377 that lacked its own signal se-
quence (the 25-221 amino acid residues of the native
HP0377) and contained a C-terminal 6 His tag was purified
from E. coli cytoplasm and used in both assays. We found
that exposure of HP0377 to glutaraldehyde, which stabilizes
oligomeric proteins by covalent crosslink formation, re-
sulted in generation of a protein with a molecular weight of
48 kDa. This result clearly showed that HP0377 can exist as
a dimer. The size exclusion experiment showed that
HP0377 eluted as two peaks, one with an estimated mass
of 24 kDa, consistent with the size of the monomer, and
the second with estimated mass of 48 kDa, consistent with
the size of the homodimer. Thus, the presented data
allowed us to conclude that at least a portion of HP0377
exists as a dimer.
The function of thiol-oxidoreductases depends on the
pKa values of their active-site Cys residues. The pKa of the
HP0377 active site thiols was determined by observing the
change in absorption of the thiolate anion at 240 nm as a
function of pH in wt protein. The pH titration of wt
HP0377 showed two transitions, one with pKa = 3.56 ± 0.11
and the other with pKa = 9.23 ± 0.21 Fig. 6a. Because these
data are atypical for CcmGs, we constructed two single-Cys
CXXC motif mutants of HP0377 (C89S and C92S), which
allowed independent measurement of the pKa of each Cys
residue. As shown in Fig. 6b, c the C89S mutant had a
pKa = 3.46 ± 0.24 and the C92S mutant a pKa = 9.41 ± 0.15.
Fig. 2 Oxidase assay of HP0231 towards apocytochrome c (HP1227).
Two different SDS PAGEs were run to better visualize the shift between
oxidized and reduced forms of proteins. a HP0231-dependent oxidation
of reduced apocytochrome c. Lane 1, oxidized HP0231. Lane 2, reduced
HP0231, Lane 3, reduced apocytochrome c treated with oxidized
HP0231. b HP0231-dependent oxidation of reduced apocytochrome c.
Lane 1, oxidized apocytochrome c. Lane 2, reduced apocytochrome c,
Lane 3, reduced apocytochrome c treated with oxidized HP0231.
Different redox forms were detected by nonreducing SDS-PAGE
after AMS treatment, which results in an increase in the molecular mass
of reduced proteins by about 0.5 kDa per thiol group
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These results agreed with the titrations of the wt pro-
tein. The pKa value of the solvent-exposed active site
cysteine (Cys89) is about 3.5. This is relatively acidic
compared with the solvent-exposed active site cysteine
of the E. coli CcmG protein, pKa = 6.8 [44], or the B.
subtilis ResA, pKa = 8.8 [45]; it is as acidic as E. coli
DsbA, which is a known oxidant whose pKa of the
solvent-exposed active site cysteine is 3.5 [38], and it is
close to the pKa of EcDsbC, 4.1 ± 0.3 [46]. Thus,
HP0377 is the first described CcmG protein having an
acidic pKa of the N-terminal cysteine of the CXXC
motif, and at the same time, it presents a low redox
potential.
HP0377 is an essential protein for H. pylori
To investigate the function of HP0377 in H. pylori we de-
cided to construct an isogenic hp0377 knock-out strain by
allelic exchange. Initial attempts to knock out hp0377 using
kanamycin or chloramphenicol antibiotic cassettes and the
allelic exchange methodology failed. Several laboratories
have reported that loss of active CcmG can be compen-
sated by the addition of reducing agents to the growth
medium. Therefore, we tested whether the addition of the
DTT into growth medium enable us to obtain an H. pylori
N6/26695 hp0377 mutated strain. It did not. Moreover, our
attempts at trans-complementation of a genomic deletion
with a plasmid-borne copy of hp0377, based on the strategy
using modified pHeL2 complementing plasmids of low and
high copy number described by Boneca et al. were also un-
successful [47].
Taken together, these studies, in combination with our
observation that a H. pylori hp0265 mutated strain can
only be generated in the presence of a reducing agent,
suggest that both HP0377 and HP0378 provide an essen-
tial function in H. pylori.
HP0265 is a redox partner of HP0377
Dsb proteins that play a role in a cytochrome-c biogen-
esis, in both system I and system II, are kept in the re-
duced form by the integral membrane protein DsbD, or
its shortened analogue CcdA. Both proteins catalyze the
transfer of electrons from cytoplasmic thioredoxin
across the inner membrane to the periplasm; however
the mechanism of the process in the case of CcdA is still
unknown [48]. Apart from HP0265, which was described
as CcdA, a search for Dsb homologs in the H. pylori
genome, employing the E. coli Dsb sequence as a query
sequence, revealed that H. pylori contains another DsbD
homolog (i.e., HP0861). Similar to Rodobacter capsulatus
CcdA and Bacillus subtilis CcdA, HP0265 is a six-
transmembrane (TM) protein containing two cysteines
at the end of the first and the fourth TM segments [48].
HP0861, however, has five cysteines with an unusual,
and as yet uncharacterized, spatial arrangement, and it
could be involved in a process other than the cyto-
chrome c biogenesis. Thus, to establish whether HP0265
is responsible for re-reducing HP0377, we created a H.
pylori strain lacking hp0265. The recombinant plasmid
pUWM2019 (based on a vector non-replicating in
Fig. 3 Isomerase activity assay. The reaction contained 40 μM scrambled RNase in 200 mM potassium phosphate buffer, pH 7.0, 2 mM EDTA, 20
μM DTT, and 9 mM cCMP. The reaction was performed in the absence or presence of 20 μM EcDsbC, 20 μM HP0377. The cleavage of cCMP by
refolded RNase was monitored continuously at 296 nm. The changes in the absorbance at 296 nm as a function of time are presented. Three
independent experiments were performed
Fig. 4 Glutaraldehyde crosslinking of HP0377. Purified HP0377 at 2.5
mg/ml was cross-linked in the presence of different concentration of
glutaraldehyde: lane 1–purified HP0377 protein, lane 2–0.001 %, lane
3–0.005 %, lane 4–0.01 %, lane 5–0.05 %, lane 6–0.1 % glutaralde-
hyde. M–monomers, D–dimers
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Helicobacter cells) was used for the mutagenesis. The
plasmid contains the hp0265 gene disrupted by insertion
of a kanamycin resistance cassette into the gene coding
sequence. The hp0265 mutants were only produced in
the presence of the reducing agent DTT, which indicates
the importance of HP0265 and its reducing activity for
bacterial survival. We then tested whether deletion of
hp0265 affects the redox state of HP0377. We noticed
that growth of the hp0265 mutated strain without DTT
was much slower than growth of the wt strain (Fig. 7).
Therefore, to check the influence of HP0265 on the
HP0377 redox state, the H. pylori N6 hp0265− strain
was cultivated 24 h longer than the wt strain to achieve
the same cell density. As shown in Fig. 8a, the knock-
out of hp0265 results in the accumulation of a notice-
able amount of HP0377 in the oxidized state, which
Fig. 5 Size exclusion profile of the purified HP0377 separated on a Superdex75 HiLoad 16/600 column (GE Healthcare) and monitored by absorbance at
280 nm. HP0377 elutes as a two peaks at 61 min, with an estimated mass of 48 kDa, consistent with the size of the homodimer and 66
min. with estimated mass of 24 kDa, consistent with the size of the monomer. The column was calibrated with Gel Filtration Standard (Bio-Rad):
Thyroglobulin (670 kDa), γ-globulin (158 kDa), Ovalbumin (44 kDa), Myoglobin (17 kDa), Vitamin B12 (1.35 kDa). The relative positions of the chosen
standards are marked with arrows
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indicates the role of HP0265 in re-reducing HP0377.
The addition of DTT to the medium resulted in the
presence of HP0377 in the reduced form, clearly verify-
ing the role of HP0265 (Fig. 8b).
Localization of HP0377
Most of the CcmG proteins are membrane-anchored via
the N-terminal transmembrane domain. In silico analysis
Fig. 6 Thiol ionization equilibrium in HP0377 followed by UV
absorbance at 240 nm. Panel a: HP0377 wild type. Panel b: HP0377 C89S.
Panel c: HP0377 C92S
Fig. 7 Effect of DTT on Helicobacter pylori hp0265− growth. Cultures
of H. pylori hp0265− were grown in Brain Heart Infusion (BHI) broth
supplemented with 10 % fetal bovine serum and kanamycin. One
culture was additionally supplemented with 2 mM DTT. As a control
wild type of Helicobacter pylori N6 was grown under the same conditions
Fig. 8 Redox state of HP0377 in wt and mutant: hp0265::aph measured
for cells grown in the absence (a) or presence (b) of DTT. Bacterial
cultures were treated with 10 % TCA, followed by alkylation with
AMS. Cellular proteins including the reduced (red; DTT treated,
modified with AMS) and the oxidized (ox; non-modified with AMS)
controls were separated by 14 % SDS-PAGE under non-reducing
conditions, and Western blot analysis using antibodies against
HP0377 was performed. Each lane contains proteins isolated from
the same amount of bacteria
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(HMM Expasy, TOPCON, Smart programs) did not in-
dicate the presence of the transmembrane N-terminal
domain in HP0377, though it confirmed the occurrence
of this kind of domain located in the N-terminus of B.
subtilis ResA. At the same time, in silico analysis using
the LipoP 1.0 server showed that the HP0377 amino-
acid sequence contains a putative signal sequence that
can be processed by signal peptidase II, which suggested
that HP0377 is an inner membrane lipoprotein. To confirm
the predicted localization of HP0377 in H. pylori, a subcel-
lular fractionation experiment was carried out. Detection of
HP0377 with specific rabbit antibody against rHP0377 re-
vealed that HP0377 is present in the inner membrane pro-
teins compartment (Fig. 9a). As a control for the method of
subcellular fractionation of H. pylori used, we traced the
cellular location of DsbI (i.e., HP0595), which is an inner-
membrane protein (Fig. 9b).
HP0377 contains an LSAC motif located in the
C-terminal of its potential signal sequence. It has been
shown that the two main strategies commonly used to
confirm lipid modification of a protein (radiolabeling
with palmitic acid and inhibition of the signal peptid-
ase II activity by globomycin) have not worked in H.
pylori [49, 50]. Thus, to provide further insight into
the role of LSAC motif of HP0377, we carried out ala-
nine mutagenesis of C25. A gene encoding the C25A
mutated protein was cloned into pHel2 and intro-
duced into H. pylori N6. In this experiment, we used
the wt strain as we had not been able to generate a
knock-out of hp0377. We expected that the mutated
form of the HP0377 (C25A), overexpressed from the
plasmid, would locate in the periplasm or cytoplasm.
We found that the overexpression of HP0377 had no effect
on cell growth and that the changing C25 into A in the
LSAC motif of HP0377 did not influence its anchoring to
the cytoplasmic membrane (data not shown).
HP0377 is not active in E. coli cells
To test whether it would be possible to study hp0377 activ-
ity in E. coli cells, the hp0377 gene was cloned with its own
promoter into a shuttle plasmid, pHEL2 (pUWM399), and
introduced by transformation into wild-type E. coli, and
into E. coli dsbA and E. coli dsbC mutated cells. The pres-
ence of HP0377 protein expressed from recombinant plas-
mid in E. coli cells was confirmed by Western blot analysis
using specific rabbit anti-HP0377 serum (Additional file 4:
Figure S4). We found that HP0377 does not restore the
dsbA wild type phenotype, as measured by motility and
DTT tests, as well as by the alkaline phosphatase assay
(Additional file 5: Figure S5). Moreover, HP0377 is not able
to complement the E. coli dsbC mutant, as measured by
the copper sensitivity assay (Additional file 6: Figure S6).
To clarify the lack of complementation of the EcdsbC
mutation by HP0377, we determined its redox state in E.
coli cells. In both the E. coli wild type and in dsbD mu-
tated cells, HP0377 exists in an oxidized form, in con-
trast to what was observed in H. pylori, where it was
present in a reduced form (Fig. 10). These results sug-
gest that HP0377 does not cooperate with E. coli DsbD.
The H. pylori genome does not contain a dsbD gene,
and HP0377 is reduced by CcdA (HP0265). Thus, to
start analysis of the HP0377 function in an E. coli back-
ground, we attempted to introduce hp0265 into E. coli.
We cloned hp0265 into the low copy number plasmid
pMPM-K6Ω, which has an arabinose inducible pro-
moter. After the correctness of the recombinant plasmid
construction was verified by sequencing, the plasmid
was introduced by transformation into wt E. coli and a
dsbD mutant E. coli that harbored a plasmid expressing
HP0377. When the expression of hp0265 was induced
by 0.2 % arabinose, the production of HP0265 was lethal
for cells (Additional file 7: Figure S7).
Fig. 9 Localization of HP0377. Panel a: Immunoblot analysis with
subcellular fractions of H. pylori strain 26695 using anti-HP0377 antibody.
Lanes: 1 - whole cell lysate; 2 - periplasmic proteins; 3 - protein
ladder; 4 - cytoplasmic proteins, 5 - inner membrane proteins; 6 - outer
membrane proteins; 7 - membranes protein. Panel b: Immunoblot
analysis with subcellular fractions of H. pylori strain 26695 using
anti-DsbI antibody. Lanes: 1 - whole cell lysate; 2 - periplasmic proteins;
3 - protein ladder; 4 - inner membrane proteins; 5 - outer membrane
proteins; 6 - membrane proteins, 7 - cytoplasmic proteins
Fig. 10 Redox state of HP0377 in wt and dsbD mutant E. coli strain
transformed with pUWM399 carrying hp0377. Bacterial cultures were
treated with 10 % TCA, followed by alkylation with AMS. Cellular proteins
including the reduced (red; DTT treated, modified with AMS) and
the oxidized (ox; non-modified with AMS) controls were separated by
14 % SDS-PAGE under non-reducing conditions, and Western blot
analysis using antibodies against HP0377 was performed. Each lane
contains proteins isolated from the same amount of bacteria
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Discussion
HP0377 is a thioredoxin-fold protein containing the
CSYC motif, which indicates that it functions as a disulfide
oxidoreductase. Although there is no evidence that HP0377
is involved in cytochrome c assembly in vivo, that is the
likely case because its resolved structure is similar to that of
other CcmG proteins, and because it is able to reduce the
oxidized form of apocytochrome c in vitro [23]. Addition-
ally, it is co-transcribed with the ccsBA (hp0378) gene that
is involved in heme transport and its ligation to apocyto-
chrome c [20, 21]. In this work we have showed that
HP0377 is present in vivo in the reduced form, which is a
characteristic feature of thiol oxidoreductases being reduc-
tants. The HP0377 redox state in vivo is consistent with its
redox potential determined by us (-171 mV) and by others
(-180 mV), which classifies HP0377 as a mild reductant.
This value is in good accord with the standard redox poten-
tial determined for the most gram-negative CcmG proteins,
such as EcCcmG (-178 mV), BjCcmG (-217 mV) or
PaCcmG (-213 mV) [51–53]. Additionally, we have shown
that HP0377, like other CcmGs, does not reduce insulin.
This finding is consistent with a generally accepted view
that CcmG proteins are specific thiol-oxidoreductases in-
volved in only the cytochrome c maturation pathway. So
far, the only known exception to this rule is TlpA from B.
japonicum. This protein is a reductant for the copper
metallochapherone Scol, but it also acts in the cytochrome
maturation process and catalyzes the insulin reduction [54].
The TlpA structure, when compared to other CcmGs, re-
vealed some unusual properties that potentially substantiate
its activity in the insulin reduction assay [55, 56]. Although
HP0377 is inactive in the insulin reduction assay, it confers
a disulfide isomerase activity almost as high as that of
EcDsbC. This atypical HP0377 attribute is in accord with
its capability to generate a dimeric form, as shown by size
exclusion and glutaradehyde crosslinking methods. It
should be noted, in contrast to our data, that Yoon et al. re-
ported that HP0377 is monomeric. As we and Yoon et al.
used almost identical recombinant HP0377 proteins, the in-
consistency may result from various experimental methods
employed [22]. Furthermore, the pKa of the N-terminal
cysteine of the CXXC motif of HP0377 appears to be simi-
lar to those observed for EcDsbC or EcDsbA but not to
those determined for most CcmGs. This observation sug-
gests that the activity of HP0377 in H. pylori, which pos-
sesses only two proteins having a TRX fold with the CXXC
motif (i.e., HP0231 and HP0377), is distinct from that de-
scribed for the classical CcmGs. Taking into account that
there is no classical DsbC protein in the H. pylori proteome
and the dimeric HP0231 does not catalyze the recovery of
active RNase from scrambled RNase (unpublished data),
we concluded that HP0377, in contrast to most CcmGs
that are involved in only the cytochrome c biogenesis
process, is at least a bifunctional reductase. Figure 11
presents a model of HP0377 functioning. As the gel filtra-
tion experiment indicated that HP0377 exists as a mixture
of monomeric and dimeric forms, its dual function may be
regulated by the mutual ratio between the two forms. This
suggestion is also supported by our interesting finding that
HP0377 is essential for cell viability. Additionally, the in
vivo experiments provide some intriguing data. We have
noticed that the in vivo redox state of HP0377 is condi-
tioned by the presence of HP0231 or HP0595. Previous ex-
periments on the function of HP0231 showed that it is a
periplasmic oxidase, and that HP0595 is partially respon-
sible for HP0231 reoxidation. Therefore, they create a redox
pair playing a role in introduction of disulfide bonds [31].
As H. pylori does not encode a classical DsbA, HP0231
may oxidize apocytochrome c just after its transport across
the inner membrane. By analogy to the function of B. subti-
lis ResA, we suggest that lack of oxidized apocytochrome
c in hp0231 mutated cells prevents HP0377 from reacting
with its redox partner (i.e., HP0265), so a part of HP0377
remains in the oxidized form [57]. However this hypothesis
requires verification because HP0377, as indicated by bio-
chemical characterization, may also play a role in processes
other than the cytochrome c maturation process. Overpro-
duction of the periplasmic thiol oxidases, HP0231 and
HP0595, results in changes to the mutual ratio of the re-
duced and oxidized forms of HP0377. As in the hp0231
mutated cells, only part of HP0377 is present in a reduced
form. Since the presence of this form is necessary for
HP0377 to fulfill its function, we decided to compare the
cytochrome c activity in hp0231 mutated cells to that ob-
served in wt cells, using the TMPD-oxidation assay. TMPD
(N,N,N′,N′-Tetramethyl-p-phenylenediamine) is an artifi-
cial substrate of cytochrome c oxidase [58]. We did not ob-
serve any differences in bacterial cell pigmentation (data
not shown), indicating that when the main periplasmic oxi-
dase, i.e., HP0231, is absent, full HP0377 activity is probably
dispensable for cytochrome c biogenesis.
Most of the gram-negative bacteria CcmGs are
membrane-anchored, periplasm-facing proteins [2]. We
also tested the subcellular localization of HP0377 by
cell fractionation experiments, which showed that it is
present in the inner membrane proteins fraction. These
data contradict those of Yoon et al., who classified
HP0377 as periplasmic protein [22]. HP0377 contains a
putative signal sequence with a lipobox (LSAC) that
can potentially be processed by signal peptidase II,
which is specific for lipoprotein precursors [59]. It has
been shown that a lipoprotein signal peptidase gene
(hp0074) is present in the H. pylori genome and that it
is essential for this bacterium [28]. However current
knowledge about the mechanism for lipoproteins trans-
port across the inner membrane and their sorting in H.
pylori is still limited and comes mainly from bioinformatic
studies [60]. We hypothesize that HP0377 is a lipoprotein
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similar to two well-characterized H. pylori lipoproteins,
Lpp20 and HpaA, which also contain a lipobox (LVGS) and
show inhibited processing, at least when expressed in E. coli
cells, by a globomicin, a cyclic peptide antibiotic specific for
signal peptidase II [49, 50]. Unexpectedly, changing the C
of the LSAC HP0377 motif into A did not influence its cell
localization. Understanding the role of the HP0377 lipobox
requires more investigation, as has been done for some
Legionella lipoproteins [61].
CcmG proteins that play a role in a cytochrome c bio-
genesis, in both system I and system II, are kept in the
reduced form by the integral membrane protein DsbD
or its shorter analogue, CcdA. Both proteins catalyze the
transfer of electrons from cytoplasmic thioredoxin
across the inner membrane to the periplasm. DsbD
consists of eight transmembrane segments (β domain),
an N-terminal (α domain) and a C-terminal domain
(γ domain). Both the N- and C-terminal domains face
the periplasm [62, 63]. CcdA, which is a shorter ver-
sion of DsbD, consist of only the β transmembrane do-
main of DsbD. In contrast to DsbD, which transfers
reducing potential to a large number of periplasmic
proteins, CcdA was thought to be only involved in the
cytochrome c maturation process [48, 64]. However,
recently published data, have showed that in Bacillus
subtilis or B. anthracis CcdA plays a role also in
Fig. 11 Models representing the role of H. pylori HP0377 in cytochrome c biogenesis and in oxidized protein folding. Following synthesis, apocytochrome
c is translocated across the membrane by the Sec protein complex, and there it is oxidized by HP0231 (periplasmic dimeric oxidoreductase). Subsequently,
its CXXCH motif is reduced by HP0377, and it is ligated to heme. Likely, as observed for other microorganisms, some molecules of the apocytochrome c
are not oxidized and are directly ligated with heme (HP0231-independent pathway). Lack of HP0231 prevents HP0377 reduction by HP0265.
A small portion of HP0377 is present in a dimeric form and potentially plays a role in the Dsb isomerization/reduction pathway. So far, the substrates of
this pathway remains unknown
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sporulation and virulence [65, 66]. Recently a new
class of DsbD proteins, named ScsB – which have a
domain organization similar to but not identical with
that of DsbD – has been described. However, their role
in CcmG re-reduction has not yet been analyzed [67]. We
show that HP0377 is kept in the reduced form by HP0265
and does not cooperate with E. coli EcDsbD. In contrast to
our data, it was demonstrated by Katzen et al. that
CcdA from Rhodobacter capsulatus complements an
E. coli dsbD gene deletion, and EcDsbD complements
the lack of RcCcdA [48]. However, R. capsulatus is dif-
ferent from H. pylori and B. subtillius, in that it has a
CcdA and an ScsB. In the publication that describes the E.
coli DsbD that reduces R. capsulatusCcmG in the absence
of its CcdA, the authors failed to knock out the ScsB [67].
Due to the structural resemblance, it is possible that ScsB
complements the absence of CcdA. Hence, the conclusion
that E. coli DsbD transfers electrons to theR. capsulatus
CcmG might have been misleading. The two conserved
cysteine residues of CcdA are membrane-embedded, and
CcdA lacks the corresponding alpha and gamma domains
of DsbD. The mechanism of transmembrane electron
transfer by CcdA is still inexplicable. It is likely that it
adopts an hourglass-like structure, similar to the Dsb β do-
main, that allows it to interact with cytoplasmic thioredoxin
and its periplasmic partners [68, 69]. We suggest that any
DsbD can only transfer electrons in a proteome that has ei-
ther a DsbD or a ScsB, but not in a proteome that has only
a CcdA. The effective transmembrane electron transfer is
also determined by the structure of the proteins that are
substrates of the envelope DsbD or DsbD–like proteins.
The best example is the Legionella pneumophila Dsb sys-
tem. This bacterium produces two DsbA-like proteins
(monomeric LpDsbA1 and dimeric LpDsbA2), two DsbBs
and two DsbDs. The DsbD-like proteins differ in their
structure: LpDsbD1 resembles EcDsbD, whereas LpDsbD2
lacks the α domain present in EcDsbD. LpDsbA2, the
bifunctional protein acting as an oxidase and isomerase,
interacts with both LpDsbDs and also with EcDsbD,
whereas EcDsbC is not reduced by LpDsbD1 or by
LpDsbD2 [70, 71]. Therefore, E. coli DsbD reduces Borde-
tella CcmG, and not HP0377, because the Bordetella gen-
ome encodes a DsbD, while the H. pylori proteome has a
CcdA but no DsbD/ScsB [67]. Similarly, B. subtilis has a
CcdA but no DsbD/ScsB, and therefore E. coli DsbD will
not reduce its CcmG.
Conclusions
The fact that H. pylori contains only two classical Dsb pro-
teins, and at the same time, its genome encodes many pro-
teins containing consecutive and nonconsecutive disulfide
bonds, implies the presence of an atypical Dsb protein net-
work. The experimental results presented strongly suggest
that HP0377, despite a structural similarity to other
CcmGs, functions differently from them. Biochemical ana-
lysis leads us to conclude that HP0377 is a multifunctional
protein. As H. pylori possesses several proteins containing
nonconsecutive disulfide bonds, we postulate that the ac-
tivity of HP0377 complements the lack of a classical DsbC.
Also, analysis of the HP0377 redox state in wt or dsb mu-
tant H. pylori cells supports this assumption, as it indicates
cooperation between the dimeric oxidoreductase HP0231
and HP0377. However, further biochemical or structural
experiments are required to confirm the nature of potential
interaction between HP0377 and HP0231, and to identify
substrates of HP0377, if any.
Additional files
Additional file 1: Figure S1. Analysis of redox state of HP0377. Analysis
of redox state of 6xHis-HP0377 in the buffer containing 0.1 mM GSSG
(oxidized glutathione) and an increasing concentration of GSH (reduced
glutathione). Fractions were resolved by (12 %) SDS PAGE, followed by gel
staining with Coomassie Brilliant Blue. The diagram represents determination
of the redox potential by equilibration against glutathione. The fraction (R)
of reduced HP0377 at equilibrium was measured by analysis of redox state,
and the intensity of the bands corresponding to the reduced protein
compared to intensity corresponding to a protein in both forms was
measured by ImageJ program.
Additional file 2: Figure S2. The insulin reduction assay. The reaction
contained 150 μM insulin in potassium phosphate buffer, pH 7.0 and
2mM EDTA. The reaction was performed in the absence or presence of
10 μM EcDsbA, 10 μM HP0377. Reactions started by adding DTT to the
final concentration of 1 mM. The changes in the absorbance at 650 nm
as a function of time were measured. Three independent experiments
were performed.
Additional file 3: Figure S3. Oxidase activity assay. The reaction
contained 10 μM reduced RNase in 100 mM Tris acetate, pH 8.0, 2 mM
EDTA, 0.2 mM GSSG, 1 mM GSH, and 9 mM cCMP. The reaction was
performed in the absence or presence of 20 μM EcDsbA or 20 μM
HP0377. The changes in absorbance at 296 nm were measured as a
function of time. Three independent experiments were performed.
Additional file 4: Figure S4. Production of HP0377 in E. coli. Plasmid
pUWM399 was introduced to E. coli. The expression of the heterologous
gene was confirmed by Western blot using anti-HP0377 antibody. Lanes:
1 – protein ladder, 2 – E. coli dsbA::kan, 3 – E. coli dsbA::kan1 with empty
pHEL2, 4 - E. coli dsbA::kan1 with pUWM399 (*) unspecific signals recognized
by anti-HP0377 antibody.
Additional file 5: Figure S5. HP0377 doesn’t restore the E. coli dsbA−
wild type phenotype in three independent functional assays. As a
negative control E. coli dsbA::aph was transformed with an empty
pHEL2 vector. (A) motility assay; (B) alkaline phosphatase assay.
(C) DTT sensitivity assay.
Additional file 6: Figure S6. HP0377 does not restore the E. coli dsbC−
wild type phenotype in the copper sensitive assays. As a negative
control E. coli dsbC::aphwas transformed with an empty pHEL2 vector. The
numbers indicate: 1 – WT, 2 - dsbC::kan, 3 – dsbC::kan/hp0231+, 4 – dsbC::kan/
hp0377, 5 – dsbC::kan/pHEL2.
Additional file 7: Figure S7. Production of HP0265 is lethal in E. coli.
The diagrams show growth curves of different strains of E. coli :
PR580(dsbD−, hp0377
+), PR581 (wt, hp0377+), PR539(dsbD−, hp0377
+, hp0265
under arabinose promotor), PR540 (wt, hp0377
+, hp0265 under arabinose
promotor. Bacteria were grown in LB at 37 °C without (A) or with addition of
0.2 % arabinose (B) at the time indicated with a black arrow.
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